Meng et al. suggested that ezrin might play functional roles in promoting the morphology, growth, motility, and invasion of pancreatic cancer cells and, further, that the Erk1/2 pathway may be involved in these roles [28-30]. This evidence concerns the gene MAPK3 and pancreatic neoplasm.